2026. Targeting mTORC1 and AMPK Signaling: Potential Therapeutic Approaches for Idiopathic Pulmonary Fibrosis. Advances in World Medical Research. 2, 1 (Feb. 2026), 1–20. DOI:https://doi.org/10.71204/99f36029.